Oct. 4–7, 2017
Indianapolis, IN
Congress Program Sections
Industry Symposia
All sessions will be held at the Indianapolis Marriott Downtown, 350 W. Maryland St., Indianapolis, IN 46225, free of charge, and most are approved for CRCE. Attendance is limited. Pre-registered Congress attendees were invited via email to register for these symposia. However, there may still be space available. For availability and to register, check with the exhibitors that are presenting them. The AARC is not responsible for information presented at these sessions.
Wednesday, Oct. 4
6:15 am–8:00 am | Marriott Ballroom 6
Idiopathic Pulmonary Fibrosis: Respiratory Care Here and Now
Karen Gregory, DNP, APRN, CNS, RRT, AE-C, FAARC
Gregory P. Cosgrove, MD
Amy L. Olsen, MD, MSPH
Provided by Vindico Medical Education
This activity is supported by an educational grant from Genentech, Inc.
Program Overview
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic lung disease of unknown cause. It is the most common diagnosis among the interstitial lung diseases. As the population ages, respiratory therapist services provided to patients with IPF will increase. This educational activity for respiratory therapists will address the basics of diagnosis, new therapeutic advances, and disease-specific requirements for pulmonary rehabilitation, as well as provide information on how to best to incorporate services to patients with IPF into their clinical practice.
Learning Objectives
- Explain the criteria used in the differential diagnosis of idiopathic pulmonary fibrosis.
- Assess the evidence base on conventional management, as well as recently-approved pharmacotherapies for the treatment of idiopathic pulmonary fibrosis.
- Determine which components should be included in a comprehensive pulmonary rehabilitation program for patients with idiopathic pulmonary fibrosis.
This course has been approved for 1.25 hours of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 149345000.
6:30 am–8:15 am | Marriott Ballroom 5
Nasal High Flow Across the Care Continuum
Keith Lamb BS, RRT-ACCS
Dr. Tommasso Mauri, Milan, Italy
Dr. Jean Pierre Frat, Poitiers, France
Dr. Gonzalo Hernandez, Madrid, Spain
Presented by Fisher & Paykel Healthcare
Program Overview
Come join us for breakfast where you shall have the opportunity to enjoy our hospitality and hear from three of the world’s leading experts on the application of high flow nasal cannula therapy and its mechanisms of action. Yes it’s an early start, but we know you won’t be disappointed.
Learning Objectives
- Identify the current evidence for Nasal High Flow (NHF) therapy, including mechanisms of action.
- Evaluate the emerging and clinically significant applications for NHF therapy.
- Discuss the evidence regarding the use of NHF, in a variety of settings.
A hot breakfast buffet will be provided.
This course has been approved for 1.75 hours of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 149293000.
5:15 pm–7:45 pm | Marriott Ballrooms 6–9
Why Long-Acting Dual Bronchodilation Should be Used in COPD
James P. Lamberti, MD, FCCP, Falls Church, VA
Presented by Sunovion Pharmaceuticals Inc.
Program Overview
Gain insight concerning the data supporting the most recently launched LABA/LAMA in the U.S.
Learning Objectives
- Understand GOLD Guideline recommendations for dual LABA/LAMA maintenance therapy in patients with COPD.
- Discuss the profile of a patient with COPD who may be appropriate for dual LABA/LAMA maintenance therapy.
- Review the efficacy and safety profile of a LABA/LAMA therapy for the long-term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.
Hors d’oeuvres and beverages will be served.
Registration
Send your name, employer, work address, and email to Doug Scarsi at dscarsi@hybridhealth.com to register.
This course has not been approved for Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care.
Thursday, Oct. 5
6:00 am–8:00 am | Marriott Ballroom 6
Personalized Ventilation: The Importance of the Diaphragm for Successful Weaning
Troy Whitacre RRT, Columbia, MO
Erik J. Boergesson BS, RRT-NPS, Syracuse, NY
Presented by Getinge
Program Overview
At the Getinge Sunrise Symposium 2017 we will explore Personalized Ventilation using NAVA® (Neurally Adjusted Ventilatory Assist) technology and the monitoring of Edi (Electrical activity of the diaphragm), with a special focus on the adult patient. The speakers will share their experience of the importance of an active diaphragm, working in synchrony with the ventilator. They will present how this may help you reduce complications, increase patient comfort, reduce sedation and wean patients earlier.
Learning Objectives
- Gain valuable insight into the importance of an active diaphragm and ventilator working in synchrony.
- Learn how diaphragm/ventilator synchrony may help you reduce complications and wean patients earlier.
- Explore how diaphragm/ventilator synchrony can lead to increased patient comfort and reduced need for sedation.
A hot breakfast buffet will be provided.
This course has been approved for 2.0 hours of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 149352000.
6:30 am–8:15 am | Marriott Ballroom 5
Patient-Centered Approaches to the Management of COPD
Brian W. Carlin MD, FCCP, MAACVPR, FAARC, Pittsburgh, PA
Krystal Craddock BSRC, RRT-NPS, AE-C, CCM, Sacramento, CA
Provided by Integrity Continuing Education, Inc.
Supported by an educational grant from Sunovion Pharmaceuticals, Inc.
Program Overview
The burden of chronic obstructive pulmonary disease (COPD) on today’s healthcare landscape remains high, and addressing this burden requires increased vigilance of changing COPD symptoms and risk factors for exacerbations and hospitalizations. It also requires that specialty providers evaluate patient status and provide therapies matched to individual patient needs. This program aims to address gaps in healthcare provider ability to recognize individualized risk factors in patients with COPD, as well as improving collaboration between inpatient and outpatient providers.
Learning Objectives
- Describe a long-term management plan that improves disease monitoring, risk assessment, and exacerbation prevention in patients with COPD.
- Review the efficacy and safety of newer bronchodilator therapies and their combinations for patients with COPD.
- Select COPD medications and their devices based on the individualized needs of patients with COPD.
This course has been approved for 1.25 hours of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 149347000.
12:30 pm–1:30 pm | Marriott Ballroom 6
The Role of Respiratory Care Professionals in the Management of Patients with Idiopathic Pulmonary Fibrosis
Dennis K Zawadski MD, FACP, FCCP, Indiana University — Ball Memorial Hospital
Presented by Boehringer Ingelheim
Program Overview
In this symposium, the faculty will highlight how respiratory care professionals participate in the management of symptoms and comorbidities for patients with idiopathic pulmonary fibrosis (IPF). The program will begin with an IPF Patient Mentor, and will continue with an introduction to IPF, followed by recommendations for disease and symptom management of patients with IPF.
Learning Objectives
- Review important topics related to the understanding of IPF, including incidence/prevalence, disease course, and key diagnostic features.
- Outline strategies for management of IPF and its symptoms, as well as support strategies for patients with this disease.
- Provide an overview of the role respiratory care professionals play in the management of comorbidities of patients with IPF.
Lunch will be provided.
Registration
Onsite registration/admission will occur for conference registrants only at the symposium entrance, on a first-come first-served basis.
This is a non-CME event and does not qualify for CME or CE credit.
5:15 pm–7:00 pm | Marriott Ballroom 5
The 2017 GOLD Update: Incorporating the New COPD Treatment Recommendations into Clinical Practice
Krystal Craddock RRT, NPS, CCM, UC Davis
Alan G Kaplan MD, CCFP(EM) FCFP, University of Toronto
Presented by Boehringer Ingelheim
Program Overview
GOLD recently released an updated strategy for management of COPD based on expert opinion and current data. Experts will review the 2017 update and discuss implications of GOLD recommendations on clinical practice, with a focus on the refined ABCD assessment tool and treatment algorithm. Panelists and attendees will interactively examine patient cases, demonstrating applicability of GOLD treatment recommendations in real-world settings.
Learning Objectives
- Understand the recent updates to the “Global Strategy for the Diagnosis, Management and Prevention of COPD” 2017 Report.
- Become familiar with the refined ABCD assessment tool and treatment algorithm.
- Increase participants understanding of the implications of the GOLD recommendations on clinical practice by reviewing patient cases demonstrating applicability of GOLD treatment recommendations.
A hot plated dinner will be provided.
This is a non-CME event and does not qualify for CME or CE credit.
Friday, Oct. 6
6:00 am–8:00 am | Marriott Ballroom 5
Early Mobility in the ICU
Peter Morris, MD, FACP, FCCP, University of Kentucky
Presented by Medtronic
Program Overview
Medtronic is supporting early mobility through education and sharing of resources and industry standards. Join us for a breakfast symposium on Early Mobility in the ICU, with speaker Peter Morris, MD, FACP, FCCP.
Learning Objectives
- An introduction to early mobility programs in the ICU.
- The benefits of implementing an early mobility program.
- The respiratory therapist’s role in early mobility therapy.
This course is pending approval for Continuing Respiratory Care Education (CRCE) with the American Association for Respiratory Care.
6:30 am–8:00 am | Marriott Ballroom 6
RT Insights on Safe and Effective IPV Practices for Patients Who Require Ventillatory Support
Richard Branson MSc, RRT, FAARC, FCCM, Cincinnati, OH
Michael D. Davis RRT, PhD, Richmond, VA
This activity is jointly provided by Global Education Group and HealthmattersCME
This activity is supported by an independent educational grant from Mallinckrodt Pharmaceuticals.
Program Overview
There are inherent risks and safety concerns with any ventilatory mode or delivery system, as well as their management and mitigation, including the universal risk of rebound pulmonary hypertension. Key safety features available on different devices will be discussed in detail, including alarm categories and types, as well as essential clinical practices, including patient and device monitoring, adherence to FDA guidelines, accurate dose delivery, avoiding pitfalls in the drug delivery process, maintaining awareness of drug side effects, and instituting appropriate management.
A comparative assessment of each ventilatory mode and delivery system for invasive and non-invasive ventilation, including high flow nasal oxygen, CPAP, conventional ventilators, and high frequency ventilators, will be discussed. Practical issues concerning the use of different delivery systems will also be reviewed.
Learning Objectives
- Differentiate ventilatory devices based on safety features and indications for patients with PHTN.
- Identify optimal inhaled pulmonary vasodilator therapy based on the pharmacology, safety, and efficacy of individual agents for patients with PHTN who are candidates for this intervention.
- Explain how to approach the use of aerosolized pulmonary dilating agents not formulated or indicated for use by inhalation with the appropriate amount of caution.
This course has been approved for 1.0 hours of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 149369000.
12:30 pm–1:40 pm | Marriott Ballroom 6
Incident Reporting and Closing the Safety Feedback Loop
Richard Branson MSc, RRT, FAARC, FCCM, Cincinnati, OH
Presented by Mallinckrodt
Program Overview
This program provides a broad review of incident reporting at the operational, organizational, and regulatory levels. In addition, it will discuss the benefits of incident reporting and encourage its practice. This interactive program seeks to engage the audience with multiple questions that should promote a healthy discussion on the usefulness of incident reporting and its role in helping to improve the hospital’s safety culture.
Learning Objectives
- Provide respiratory therapists with an understanding of incident reporting at the operational (by clinicians) and organizational (by hospitals) levels.
- Highlight data relative to under-reporting of incidents in healthcare and discuss barriers to incident reporting.
- Educate respiratory therapists on the importance of incident reporting and provide concepts that may help increase reporting at their institution.
This course has been approved for 1.0 hours of Continuing Respiratory Care Education (CRCE) credit by the American Association for Respiratory Care. Course number: 148938000.